Trial NCT00450333

View at ClinicalTrials.gov 
Org. Study IDs: SPD490-301
Secondary IDs: 2006-002052-15

Last trial update was posted on 2021-06-14

MeSH Interventions

Epoetin Alfa

MeSH Conditions

Anemia Renal Insufficiency

Other Conditions

Kidney Failure

Stopping Reasons

The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA

Limitations And Caveats

This study terminated early due to a decision by Shire Pharmaceuticals to permanently cease marketing Dynepo due to commercial reasons, it was not the result of any safety signal. Not enough subjects completed the study to do any efficacy analyses.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID